05.20.21
Intranasal COVID-19 therapeutic shows promise in preclinical trials
The coronavirus disease 2019 (COVID-19) pandemic continues to rage in many countries over a year after it first emerged in Wuhan, China. New and more infectious severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants are emerging, with concern mounting over their natural and vaccine-induced immunity evasion potential. Rapid development and deployment of non-invasive therapeutic measures